Events

Development of next generation of anti-cancer drugs

Cancer is a deadly anomaly and despite there being several advancements in understanding its nature and formulating appropriate treatments, cancer still remains a mystery. According to the WHO, cancer is one of the leading causes of death worldwide accounting for almost 10 million deaths as of 2020. Cancer is characterized by the abnormal proliferation of cells beyond limits and its ability to spread to other organs (metastasis). 

MedPiper Technologies and JournoMed are conducting a webinar that aims to uncover some of the possible anti-cancer drug discoveries which can tackle this deadly disorder.

The event will be held on 6th August, Friday, 4 pm. Participants can join the event by registering for it here. E-Certificates will be provided to the participants. For more details, participants may contact soumya@medpiper.com / 9080078447.

Many types of cancers can be treated by “traditional” chemotherapy drug treatments, such as alkylating agents, intercalating drugs, topoisomerase inhibitors, antimetabolites, and antimitotic drugs, and more recently identified targeted therapies such as various kinase inhibitors. The targeted monoclonal antibodies have been proven to be spectacularly successful in specific cancers. A limited number of cancers can be completely cured using these treatment approaches. The success of cancer treatments varies enormously depending on the specific type of cancer diagnosed and stage of diagnosis.

The major problem while developing anticancer drugs is the presence of multidrug resistance and relapse. Classical chemotherapeutic drugs directly target the DNA of the cell, but mutations enable the cell to develop resistance. Extensive cancer research has uncovered promising drug targets for effective exploitation in the treatment of cancer.

In molecular-targeted anticancer therapy, the drugs target the proteins with an abnormal expression inside the cancer cells. Targeted chemotherapies are successful in certain malignancies; however, they can be often rendered ineffective due to drug resistance and adverse drug reactions. 

The webinar aims to provide a clearer picture of the possible types of anti-cancer solutions and the research surrounding them. There will also be discussion regarding the advancements in understanding breast cancer. 

Expert Speaker: Dr Mohan CD Assistant Professor, Department of Studies in Molecular Biology, University of Mysore, Manasagangotri

Update: The post-event summary of the webinar can be accessed here

Related Articles

Leave a Reply

Back to top button
Close Bitnami banner
Bitnami